News + Resources
Preserving Michigan’s Competitive Bioscience Industry
For over 150 years, Michigan has been at the forefront of bringing biopharmaceutical advances to patients across the country and around the world. This is not simply a byproduct of economic luck or chance, but rather the culmination of competitive mergers and...
Forbes Commentary: Trump Administration Should Reverse “Anti-Merger” Approach to M&A
The culmination of flawed antitrust policies by the Federal Trade Commission (FTC) and Department of Justice (DOJ) have discouraged pro-competitive mergers that could meaningfully benefit American consumers – a growing concern raised by former FTC general counsel and...
Innovations Advanced by M&A: New Treatment Options for Migraines
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the importance of mergers and acquisitions in ensuring a competitive and vibrant biopharmaceutical landscape for patients. You can find previous blogs in this...
CBSA: Life Sciences M&A Fuels Growth & Innovation in Colorado
In a recent blog post, PULSE partner Colorado Bioscience Association (CBSA) highlighted the fundamental role of pro-innovation mergers and acquisitions in driving life sciences innovation and economic growth in Colorado and beyond. Read their blog post below: ...
Latest Estimates Reinforce Burden of FTC’s Final HSR Rule
The Federal Trade Commission (FTC)’s recently finalized Hart-Scott-Rodino (HSR) premerger notification rule places a significant time and cost burden on companies engaging in procompetitive mergers and acquisitions (M&A), according to top legal analyses and the...